The emperor penguin, which roams Antarctica's frozen tundra and chilly seas, is at severe risk of extinction in the next 30 to 40 years as a result of climate change, an expert from the Argentine Antarctic Institute (IAA) warned.
The emperor, the world's largest penguin and one of only two penguin species endemic to Antarctica, gives birth during the Antarctic winter and requires solid sea ice from April through December to nest fledgling chicks.
Every August, in the middle of the southern hemisphere winter, Libertelli and other scientists at Argentina's Marambio Base in Antarctica travel 65 km each day by motor bike in temperatures as low as -40 degrees Celsius to reach the nearest emperor penguin colony. The emperor's unique features include the longest reproductive cycle among penguins. After a chick is born, one parent continues carrying it between its legs for warmth until it develops its final plumage.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Weiterlesen »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Weiterlesen »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to blood clot riskU.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
Weiterlesen »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Weiterlesen »
J&J COVID-19 vaccine distribution restricted due to blood clot risk, FDA saysU.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
Weiterlesen »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Weiterlesen »